Drugs Made In America Acquisition LLC 4
4 · Drugs Made In America Acquisition Corp. · Filed Feb 4, 2025
Insider Transaction Report
Form 4
Transactions
- Purchase
Ordinary shares
2025-01-29+400,000→ 10,257,143 total - Sale
Ordinary shares
2025-01-29−5,698,363→ 4,158,780 total - Purchase
Rights to receive ordinary shares
2025-01-29+400,000→ 400,000 total→ Ordinary shares (400,000 underlying) - Other
Ordinary shares
2025-01-29−400,000→ 9,857,143 total
Footnotes (4)
- [F1]Reflects the 400,000 private units owned by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $4,000,000.
- [F2]As of the Transaction Date, the reporting person transferred an aggregate of 400,000 ordinary shares to certain of the Issuer's officers and directors for no consideration.
- [F3]As of the Transaction Date, pursuant to share transfer agreements, the reporting person transferred an aggregate of 5,698,363 ordinary shares for consideration ranging from no consideration to $1.50 per share.
- [F4]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.